Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

PIII — P3 Health Partners Inc. Dilution Risk Tracker

Track PIII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PIII — Get alerts when the score changes →

As of August 28, 2026, P3 Health Partners Inc. (PIII) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. P3 Health Partners Inc. has a market capitalization of $2.48B, 3.33M shares outstanding, 10 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
10
💰 Cash Runway
95
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise model 55%
• Critical: only 2.4 months cash remaining
🔄 Reverse Split model est. 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track PIII — Get forecast alerts →

Market Data

Market Cap$2.48B
Shares Outstanding3.33M
Float1.42M
Cash$21.27M
Debt$119.85M
Short InterestN/A

Institutional Holdings

10 institutional holders · 343.8K shares
#1 Alyeska Investment Group, L.p. 137.4K shares
#2 Vanguard Capital Management LLC 70.6K shares
#3 Trinity Financial Advisors LLC 27.1K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest36.0K
Days to Cover1.7
% of Float2.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30
xbrl XBRL WARRANT 2025-12-31
4 INSIDER TRANSACTION 2026-06-12
8-K 8K EVENT 2026-06-10
4 INSIDER TRANSACTION 2026-05-18
Full SEC filing analysis available with free account

Recent News

Factual PIII Dilution Snapshot

P3 Health Partners Inc. (PIII) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PIII Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PIII — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PIII
PIII FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.